Healthpeak Properties Inc (DOC) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Healthpeak Properties Inc stock $16.07, price $20.26, that is 20.7% below the price, quality 45 out of 100. Rating: overvalued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range $12.80 – $27.82 · fair‑value band $10.31 – $25.02 · the $20.26 price screens above the $16.07 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Healthpeak Properties in your weekly email
Every Wednesday you see whether Healthpeak Properties is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985.
Show moreShow less
We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member.
We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate.
Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures.
We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein.
At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical " 530 properties; (ii) Lab " 139 properties; (iii) CCRC " 15 properties; and (iv) Other non-reportable " 19 properties.
Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.
Stock analysis
Healthpeak Properties Inc (DOC) currently trades at $20.26, while our model-based Fair Value estimate is $16.07, 21% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $24.62 per share, and 4 of the 15 models we run sit above the $20.26 price.
Bear case: the Asset-Based group reads lowest at $6.59, and 11 of the 15 models stay below the price. Data coverage for this calculation is high.
Scenario range: $10.31 (bear) to $25.02 (bull), the price of $20.26 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 45/100 (below-average quality), in the Real Estate sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Healthpeak Properties Inc reported revenue of $2.8B in FY2025 versus $1.9B in FY2021, a compound +10.5%/yr. Reported net income was $71.3M in FY2025, compounding −38.7%/yr from FY2021.
Key figures
Market cap $14.0B Large · P/E ratio 36.5 · P/S ratio 6.46 · EPS (TTM) $0.5400 · Dividend yield 6.0% · Net margin 12.3% · Return on equity 4.4% · Return on assets (EBIT) 2.5% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).
What moves the price
The share trades about 10% below its 52-week high and 35% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −19% fair-value upside, at −21%, DOC screens richer than that median.
Fair Value models
Bear$10.31Fair Value $16.07Bull$25.02
Price $20.26 · Downside -20.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, one officer or director sold shares worth $213,736 and none bought.
SaleScott R BohnCDO and Head of Lab10,989 shares at $19.45$213,736May 12, 2026
Plus 7 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.89/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+4.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.4%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
≈ +10.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year≈ +4.5%
Dividend (yield on the price)6.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−33.3% vs −29.6%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 19%
⚠ Revenue per share shrinking 1.4%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Base effect: the rate starts in the earnings trough around 2020 (starting value 0.63 per share, median 4.42 in 2015 to 2018). It measures the recovery from the trough, not lasting growth.
Growth Forecast
Price in line with expectations
The price assumes less growth than the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+6.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+5.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +4.4% a year for the price and +2.9% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (97 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
AI conclusion: Stable outpatient medical assets and capital recycling via joint ventures support payouts, yet lower-occupancy lab properties tie results to life science tenant expansion.
Main risk: Generative KI and automation could accelerate and streamline R&D functions for lab tenants leading to reconfiguration of space needs or lower demand for lab properties and thus reduced occupancy and rents.
Healthpeak Properties blends stable outpatient medical assets with improving but still lower-occupancy lab properties that together underpin its monthly payouts. Capital recycling through joint ventures and dispositions adds flexibility yet keeps results tied to how quickly life science tenants expand. Will outpatient momentum lift overall performance more than the lab segment holds it back?
Compare Healthpeak Properties Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.REIT - Healthcare Facilities · 25 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Healthpeak Properties Inc (DOC) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $16.07 versus a price of $20.26, about 21% lower (overvalued).
What is the fair value of DOC?
Our model-based fair value for Healthpeak Properties Inc is $16.07 (as of Nov 6, 2026), built from audited fundamentals. The current price: $20.26.
What is the quality score of DOC?
Healthpeak Properties Inc has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Healthpeak Properties Inc (DOC)?
Our model-based price target is the fair value of $16.07 (as of Nov 6, 2026) from 15 valuation models. Cautious scenario $10.31, optimistic scenario $25.02. It is a calculation from audited fundamentals, not an analyst target.
What is the Healthpeak Properties Inc stock forecast for 2026?
Our models put fair value at $16.07, about 21% lower versus a price of $20.26 (overvalued). Cautious scenario $10.31, optimistic scenario $25.02. The calculation is refreshed regularly with new filings.
What is the revenue of Healthpeak Properties Inc (DOC)?
Healthpeak Properties Inc reported trailing-twelve-month revenue of about $3.1B (latest available figure, as of Nov 6, 2026).
Does Healthpeak Properties Inc pay a dividend?
Healthpeak Properties Inc currently shows a dividend yield of 6.02% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Healthpeak Properties Inc (DOC) and when is the ex-dividend date?
Healthpeak Properties Inc pays a dividend of $1.22 per share a year, a dividend yield of 6.0%. The next ex-dividend date is Nov 13, 2026, with payment on Dec 30, 2026. A dividend has been paid every year since at least 1985. Free cash flow covers the dividend 1.49 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Healthpeak Properties Inc (DOC)?
For today's price to be fair in a discounted-cash-flow model, Healthpeak Properties Inc would have to grow free cash flow by +6.9 % per year for five years (discount rate 9.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +11.4 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of DOC use?
Our models discount Healthpeak Properties Inc at 9.2 %: a base by market capitalisation (large), damped by beta 0.98, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Healthpeak Properties Inc that is +6.9 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.2 %) and the same formula as our fair value.
How much growth has Healthpeak Properties Inc (DOC) delivered so far?
Over the past 5 years revenue at Healthpeak Properties Inc grew +11.4 % a year. The price currently implies free-cash-flow growth of +6.9 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Healthpeak Properties Inc (DOC) growing?
The median revenue growth in the sector is +2.7 % a year. That is the yardstick for the growth priced into Healthpeak Properties Inc (+6.9 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Healthpeak Properties Inc (DOC)?
The free-cash-flow yield on the price is 8.96 %: that much free cash flow Healthpeak Properties Inc produces per unit of market value. When it exceeds the discount rate of our models (9.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Healthpeak Properties Inc (DOC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Healthpeak Properties Inc it is $16.07 per share (as of Nov 6, 2026), against a price of $20.26. It is the blended result of 15 valuation models in 6 families (DCF Models, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Healthpeak Properties Inc stock overvalued or undervalued in 2026?
As of Nov 6, 2026, DOC trades above its calculated fair value: price $20.26, fair value $16.07, a gap of about −21% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DOC?
No. The price is what the market pays today ($20.26); the fair value is what the company's own numbers justify ($16.07). For Healthpeak Properties Inc the two are $4.19 per share apart. That gap is exactly why we show both numbers side by side.
How much is Healthpeak Properties Inc worth?
The market values Healthpeak Properties Inc at about $14.0B (market capitalisation, as of Nov 6, 2026). Per share that is $20.26; our models calculate a fair value of $16.07 per share.
What do the bullish and bearish scenarios say about DOC?
Our models span a range for Healthpeak Properties Inc: cautious scenario $10.31, base $16.07, optimistic $25.02 per share (as of Nov 6, 2026, price $20.26). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of DOC?
Healthpeak Properties Inc trades at a price-to-earnings ratio of 36.5 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $16.07 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 37.0. Other multiples: PEG 4.3, P/B 1.9, P/S 6.5, EV/EBITDA 20.2.
What is the PEG ratio of DOC?
The PEG ratio of Healthpeak Properties Inc is 4.32 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Healthpeak Properties Inc (DOC)?
Balance-sheet figures for Healthpeak Properties Inc (as of Nov 6, 2026): return on equity 4.4%, debt of 1.17 per unit of equity. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is DOC from its 52-week high?
Healthpeak Properties Inc trades at $20.26, about 10% below its 52-week high of $22.59 and 35% above the low of $15.03 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $16.07 is for.
Which stocks are comparable to Healthpeak Properties Inc?
From the same area (Real Estate) we also value Welltower Inc, Ventas, Inc, Omega Healthcare Investors, Inc, American Healthcare REIT, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Healthpeak Properties Inc stock attractive at the current price?
The data as of Nov 6, 2026: price $20.26, calculated fair value $16.07 (−21%), Quality Score 45/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DOC calculated?
We run Healthpeak Properties Inc through 15 models from 6 families: DCF Models, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of $16.07 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Healthpeak Properties Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Healthpeak Properties Inc (DOC)?
The closing price on Nov 6, 2026 was $20.26. Our model-based fair value is $16.07, about 21% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Healthpeak Properties Inc right now?
Weak quality (45/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range ($10.31 to $25.02) leaves room in how you read the outcome. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Where does the earnings growth of Healthpeak Properties Inc (DOC) come from?
Earnings per share at Healthpeak Properties Inc grew −20.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share −5.0 %, EBIT margin −7.6 %, tax rate +0.0 %, residual (interest, one-offs) −9.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Healthpeak Properties Inc
How large is the market capitalisation of Healthpeak Properties Inc (DOC)?
The market capitalisation of Healthpeak Properties Inc is $14.0B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Healthpeak Properties Inc (DOC)?
The price-to-sales ratio of Healthpeak Properties Inc is 6.46 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Healthpeak Properties Inc (DOC)?
Earnings per share at Healthpeak Properties Inc are $0.5400 (price ÷ EPS = P/E 36.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Healthpeak Properties Inc (DOC)?
The dividend yield of Healthpeak Properties Inc is 6.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Healthpeak Properties Inc (DOC)?
The net margin of Healthpeak Properties Inc is 12.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Healthpeak Properties Inc (DOC)?
The return on equity (ROE) of Healthpeak Properties Inc is 4.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Healthpeak Properties Inc (DOC)?
On an EBIT basis the return on assets of Healthpeak Properties Inc is 2.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Healthpeak Properties Inc (DOC)?
The operating margin of Healthpeak Properties Inc is 13.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Healthpeak Properties Inc (DOC)?
Revenue at Healthpeak Properties Inc is growing +16.3% versus a year earlier (3y avg +11.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Healthpeak Properties Inc (DOC)?
Earnings per share at Healthpeak Properties Inc are growing +68.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Healthpeak Properties Inc (DOC) carry?
The net debt of Healthpeak Properties Inc is $9.9B (fiscal year 2025, ≈ 7.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Healthpeak Properties Inc in the live analysis
One click puts Healthpeak Properties Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 6, 2026